2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Resected Stage III BRAF V600-mutant Melanoma: Is Dabrafenib + Trametinib an Effective Adjuvant Therapy Following Surgery With an Excellent Safety Profile?

38 views
July 17, 2020
Comments 0
Login to view comments. Click here to Login